Quantifying the change in endorectal magnetic resonance imaging-defined tumor volume during neoadjuvant androgen suppression therapy in patients with prostate cancer

Urology

Volumn 62, Issue 3, 2003, Pages 487-491

  Sanghani, Mona V ^b   Schultz, Delray ^b   Tempany, Clare M ^b   Titelbaum, David ^b   Renshaw, Andrew A ^b   Loffredo, Marian ^b   Cote, Kerri ^b   McMahon, Beth ^b   D'Amico, Anthony V ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CALCULATION; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE CARCINOMA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WILCOXON SIGNED RANKS TEST;

EID: 0041733406     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00463-1     Document Type: Article

References (21)

1. Cancer Statistics - 2003. CA Cancer J Clin. 53(1):2003;8-10.
2. Smith J.A., Scardino P.T., Resnick M.I., et al. Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate - results of a prospective, multi-institutional trial. J Urol. 157:1997;902-906.
3. Lorentzen T., Nerstrom H., Iversen P., et al. Local staging of prostate cancer with transrectal ultrasound - a literature review. Prostate Suppl. 4:1992;11-16.
4. Engeler C.E., Wasserman N.F., Zhang G. Preoperative assessment of prostatic carcinoma by computerized tomography - weaknesses and new perspectives. Urology. 40:1992;346-350.
5. Vapnek J.M., Hricak H., Shinohara K., et al. Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer. Urol Int. 53:1994;191-195.
6. Rifkin M.D., Zerhouni E.A., Gatsonis C.A., et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer - results of a multi-institutional cooperative trial. N Engl J Med. 323:1990;621-626.
7. Schnall M.D., Bezzi M., Pollack H.M., et al. Magnetic resonance imaging of the prostate. Magn Reson Q. 6:1990;1-16.
8. Krebs T.L., Silverman J.M. Clinical utility of endorectal surface coil MR imaging of the prostate gland. Radiology. 185:1992;275.
9. Quinn S.F., Franzini D.A., Demlow T.A., et al. MR imaging of prostate cancer with an endorectal surface coil technique - correlation with whole-mount specimens. Radiology. 190:1994;323-327.
10. Chelsky M.J., Schnall M.D., Seidmon E.J., et al. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol. 150:1993;391-395.
11. Perrotti M., Kaufman R.P., Jennings T.A., et al. Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer - is it accurate? J Urol. 156:1996;106-109.
12. Tempany C.M., Zhou X., Zerhouni E.A., et al. Staging of prostate cancer - results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology. 192:1994;47-54.
13. D'Amico A.V., Whittington R., Malkowicz B., et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol. 164:2000;759-763.
14. Cheng D., Tempany C. MR imaging of the prostate and bladder. Semin Ultrasound CT MR. 19:1998;67-89.
15. Sommer F.G., Nghiem H.V., Herfkens R., et al. Determining the volume of prostatic carcinoma - value of MR imaging with an external array coil. AJR Am J Roentgenol. 161:1993;81-86.
16. Pinault S., Monfette G., Tetu B., et al. Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamide. Urology. 39:1992;254-261.
17. Chen M., Hricak H., Kalbhen C.L., et al. Hormonal ablation of prostatic cancer - effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR Am J Roentgenol. 166:1996;1157-1163.
18. Nakashima J., Imai Y., Tachibana M., et al. Effects of endocrine therapy on the primary lesion in patients with prostate carcinoma as evaluated by endorectal magnetic resonance imaging. Cancer. 80:1997;237-241.
19. D'Amico A.V., Chang E., Garnick M., et al. Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging - a new predictor of tumor response to neoadjuvant androgen suppression therapy. Urology. 51:1998;287-292.
20. Padhani A.R., MacVicar A.D., Gapinski C.J., et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology. 218:2001;365-374.
21. Saitoh M., Ramirez E., Babaian R.J. Ultrasonic volume monitoring in patients with prostate cancer treated by external beam therapy. Urology. 43:1994;342-348.